InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.
Cannabis News
Vinergy Resources Ltd. and MJ Biopharma Announce Major Breakthrough
While the medicinal cannabis industry continues to rapidly advance and expand operations by identifying new leading edge products, leaders are turning towards the expertise and knowledge of other medical sectors, especially with influence from the biopharma sector.
Valens GroWorks Enters Into $1.2m Loan Repayment Agreements
Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.
Tetra Bio-Pharma Starts Phase I Clinical Study of Smoked Cannabis.
Tetra Bio-Pharma (CSE: TBP) (CSE: TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that Health Canada has approved its Phase I clinical study of smoked cannabis.
Acquisitions on the Rise as Companies Increase Revenue
The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.
As a result, M&A activity in the market is heading toward exponential growth as well.
Investing In A Different Kind Of Oil
In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?
Rising India Inc. Enters the $6.5 Billion Cannabis Industry
Rising India Inc. (OTC: RSII) announced that the company is targeting opportunities in the cannabis industry. The company is in active negotiations to reach a Letter of Intent with business operators that are currently active in the cannabis industry.
Mining for Marijuana in Canada
Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.
ChineseInvestors.com (CIIX) Issues Update on Recent Financial and Business Achievements
ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning issued a news release highlighting some of its financial and business achievements for January 2017, as well as its plans to build on these milestones moving forward.
SinglePoint, Inc. (SING) CEO Discusses Recent Share Price Increase in Interview on MoneyTV
Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
A Tetra Bio-Pharma and IntelGenx Combine for New Drug Development
Tetra Bio-Pharma Inc. (CSE: TBP, OTC:GRPOF) and IntelGenx Corp. (TSXV:IGX, OTCQX:IGXT), annouced the signing of a binding term sheet for the development and commercialization of a drug product containing dronabinol.
Ex-Medical Marijuana Officials Charged for Illegal Shipment
BY KYLE POTTER ASSOCIATED PRESS
ST. PAUL, Minn. (AP) — Prosecutors in Minnesota filed felony charges Monday against two former officials from one of the state’s licensed medical marijuana manufacturers for allegedly shipping marijuana oil to a subsidiary facility in New York.
GW Pharma Looks Better Than Ever to Investors
The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.
GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.
Invictus MD (CSE:IMH, OTC:IVITF) Acquires 150 acres to Increase Production
Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares from its current shareholders.
They have acquired 60,000 square feet of secured perimeter for its current production facility located on 150 acres. They have already submitted plans for additional buildings on the Property including a 30,000 square foot facility.
Alliance Growers Executes Founder’s Agreement with Private LP Applicant
Tel: 778-998-5431 RobGrace@alliancegrowers.com THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. FORWARD LOOKING INFORMATION This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance.